Gyre Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Gyre Therapeutics, Inc. (GYRE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 28.17 thousand shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-05-08
- Gyre Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 28.17K shares.
- Gyre Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 41.37K shares.
- Gyre Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Gyre Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-06-30 was 0.00 shares.
- Gyre Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 41.37K shares, a 355.49% increase from fiscal 2024.
- Gyre Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 9.08K shares, a 52.03% decline from fiscal 2023.
- Gyre Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 18.94K shares.
- Gyre Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2021 was 1.24M shares, a 394.58% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | 28.17K shares 10-Q · filed 2026-05-08 | 69.54K shares derived: sum of 2 quarters · filed 2026-05-08 | 69.54K shares derived: sum of 3 quarters · filed 2026-05-08 | 69.54K shares derived: sum of 4 quarters · filed 2026-05-08 | |
| 2025-12-31 | 41.37K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 41.37K shares derived: sum of 2 quarters · filed 2026-03-13 | 41.37K shares derived: sum of 3 quarters · filed 2026-03-13 | 41.37K shares 10-K · filed 2026-03-13 | |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-07 | 0.00 shares 10-Q · filed 2025-11-07 | 0.00 shares derived: sum of 4 quarters · filed 2025-11-07 | |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | 0.00 shares 10-Q · filed 2025-08-11 | 0.00 shares derived: sum of 3 quarters · filed 2025-08-11 | 5.46K shares derived: sum of 4 quarters · filed 2025-08-11 | |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-09 | 0.00 shares derived: sum of 2 quarters · filed 2025-05-09 | 5.46K shares derived: sum of 3 quarters · filed 2025-05-09 | 5.46K shares derived: sum of 4 quarters · filed 2025-05-09 | |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | 5.46K shares derived: sum of 2 quarters · filed 2025-03-17 | 5.46K shares derived: sum of 3 quarters · filed 2025-03-17 | 9.08K shares 10-K · filed 2025-03-17 | |
| 2024-09-30 | 5.46K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 5.46K shares derived: sum of 2 quarters · filed 2024-11-13 | 9.08K shares 10-Q · filed 2024-11-13 | ||
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 3.62K shares 10-Q · filed 2024-08-13 | |||
| 2024-03-31 | 3.62K shares 10-Q · filed 2024-05-13 | ||||
| 2023-12-31 | 18.94K shares 10-K · filed 2024-03-27 | ||||
| 2022-06-30 | 514.28K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 1.17M shares 10-Q · filed 2022-08-15 | 1.78M shares derived: sum of 3 quarters · filed 2022-08-15 | 2.14M shares derived: sum of 4 quarters · filed 2022-08-15 | |
| 2022-03-31 | 658.95K shares 10-Q · filed 2022-05-09 | 1.27M shares derived: sum of 2 quarters · filed 2022-05-09 | 1.63M shares derived: sum of 3 quarters · filed 2022-05-09 | 1.81M shares derived: sum of 4 quarters · filed 2022-05-09 | |
| 2021-12-31 | 607.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 968.69K shares derived: sum of 2 quarters · filed 2022-03-31 | 1.15M shares derived: sum of 3 quarters · filed 2022-03-31 | 1.24M shares 10-K · filed 2022-03-31 | |
| 2021-09-30 | 360.88K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 544.74K shares derived: sum of 2 quarters · filed 2021-11-12 | 631.83K shares 10-Q · filed 2021-11-12 | 658.76K shares derived: sum of 4 quarters · filed 2022-03-31 | |
| 2021-06-30 | 183.86K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 270.94K shares 10-Q · filed 2021-08-05 | 297.88K shares derived: sum of 3 quarters · filed 2022-03-31 | 385.96K shares derived: sum of 4 quarters · filed 2022-03-31 | |
| 2021-03-31 | 87.08K shares 10-Q · filed 2021-05-06 | 114.02K shares derived: sum of 2 quarters · filed 2022-03-31 | 202.10K shares derived: sum of 3 quarters · filed 2022-03-31 | 311.61K shares derived: sum of 4 quarters · filed 2022-03-31 | |
| 2020-12-31 | 26.93K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 115.02K shares derived: sum of 2 quarters · filed 2022-03-31 | 224.53K shares derived: sum of 3 quarters · filed 2022-03-31 | 250.64K shares 10-K · filed 2022-03-31 | |
| 2020-09-30 | 88.09K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 197.59K shares derived: sum of 2 quarters · filed 2020-11-05 | 223.71K shares 10-Q · filed 2020-11-05 | 239.71K shares derived: sum of 4 quarters · filed 2021-03-04 | |
| 2020-06-30 | 109.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 135.62K shares 10-Q · filed 2020-08-06 | 151.62K shares derived: sum of 3 quarters · filed 2021-03-04 | 258.05K shares derived: sum of 4 quarters · filed 2021-03-04 | |
| 2020-03-31 | 26.12K shares 10-Q · filed 2020-05-11 | 42.12K shares derived: sum of 2 quarters · filed 2021-03-04 | 148.55K shares derived: sum of 3 quarters · filed 2021-03-04 | 168.87K shares derived: sum of 4 quarters · filed 2021-03-04 | |
| 2019-12-31 | 16.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | 122.43K shares derived: sum of 2 quarters · filed 2021-03-04 | 142.75K shares derived: sum of 3 quarters · filed 2021-03-04 | 182.72K shares 10-K · filed 2021-03-04 | |
| 2019-09-30 | 106.43K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 126.75K shares derived: sum of 2 quarters · filed 2019-11-07 | 166.72K shares 10-Q · filed 2019-11-07 | 166.72K shares derived: sum of 4 quarters · filed 2020-02-20 | |
| 2019-06-30 | 20.32K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | 60.29K shares 10-Q · filed 2019-08-01 | 60.29K shares derived: sum of 3 quarters · filed 2020-02-20 | 80.42K shares derived: sum of 4 quarters · filed 2020-02-20 | |
| 2019-03-31 | 39.97K shares 10-Q · filed 2019-05-02 | 39.97K shares derived: sum of 2 quarters · filed 2020-02-20 | 60.10K shares derived: sum of 3 quarters · filed 2020-02-20 | ||
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | 20.13K shares derived: sum of 2 quarters · filed 2020-02-20 | 43.31K shares 10-K · filed 2020-02-20 | ||
| 2018-09-30 | 20.13K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | 43.31K shares 10-Q · filed 2018-11-01 | |||
| 2018-06-30 | 23.19K shares 10-Q · filed 2018-08-02 | ||||
| 2017-12-31 | 395.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | 36.91K shares derived: sum of 2 quarters · filed 2019-03-08 | 45.75K shares derived: sum of 3 quarters · filed 2019-03-08 | 61.25K shares 10-K · filed 2019-03-08 | 61.11K shares 10-K · filed 2018-03-19 |
| 2017-09-30 | 36.52K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | 45.36K shares derived: sum of 2 quarters · filed 2017-11-02 | 60.85K shares 10-Q · filed 2017-11-02 | -131.81K shares derived: sum of 4 quarters · filed 2018-03-19 | |
| 2017-06-30 | 8.84K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | 24.34K shares 10-Q · filed 2017-08-03 | -168.33K shares derived: sum of 3 quarters · filed 2018-03-19 | -41.70K shares derived: sum of 4 quarters · filed 2018-03-19 | |
| 2017-03-31 | 15.49K shares 10-Q · filed 2017-05-11 | -177.17K shares derived: sum of 2 quarters · filed 2018-03-19 | -50.54K shares derived: sum of 3 quarters · filed 2018-03-19 | 18.25K shares derived: sum of 4 quarters · filed 2018-03-19 | |
| 2016-12-31 | -192.66K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | -66.03K shares derived: sum of 2 quarters · filed 2018-03-19 | 2.76K shares derived: sum of 3 quarters · filed 2018-03-19 | 6.57K shares 10-K · filed 2018-03-19 | |
| 2016-09-30 | 126.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 195.42K shares derived: sum of 2 quarters · filed 2016-11-03 | 199.24K shares 10-Q · filed 2016-11-03 | ||
| 2016-06-30 | 68.79K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 72.61K shares 10-Q · filed 2016-08-04 | |||
| 2016-03-31 | 3.81K shares 10-Q · filed 2016-05-05 | ||||
| 2015-12-31 | 2.44K shares 10-K · filed 2017-03-08 | 36.55K shares 10-K · filed 2016-03-09 | |||
| 2014-12-31 | 2.28K shares 10-K · filed 2016-03-09 | ||||
| 2013-12-31 | 4.64K shares 10-K · filed 2016-03-09 | ||||
| 2012-12-31 | 892.22K shares 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |